Discontinuation report MYLAN-CLARITHROMYCIN
Report ID | 15872 |
Drug Identification Number | 02248857 |
Brand name | MYLAN-CLARITHROMYCIN |
Common or Proper name | CLARITHROMYCIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CLARITHROMYCIN |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-07-12 |
Remaining supply date | 2019-11-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | There is no saleable inventory remaining. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-07-17 | English | Compare |
v2 | 2017-07-17 | English | Compare |
v3 | 2017-07-17 | French | Compare |
Showing 1 to 3 of 3